Administration of human fibroblast interferon in chronic hepatitis-B infection.
about
Update on diagnosis, management, and prevention of hepatitis B virus infection.Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts.Interferon production: variation in yields from human cell lines.Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy.Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection.Human interferon: mass production in a newly established cell line, MG-63.Large-scale production and concentration of human lymphoid interferonHuman fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.Recent advances in the identification of hepatitis viruses.Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.Management of chronic hepatitis B infection.[Hepatitis B: current concepts].Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis.Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments.Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.Interferon: therapeutic fact or fiction for the '80s?
P2860
Q33588921-6D4C64DD-90A3-4AF2-948F-9F0A8878F3AFQ34077447-BE007AD4-A551-42B3-B695-3FA16C61BD81Q34090150-070C5CF2-E7B2-45FD-AA73-5CB1939FBC16Q34578618-B3EDBBAE-8D53-4752-935E-ADB3839133F3Q35648540-E157F111-93E4-4B3F-BA2F-7A0F371D5061Q36464405-4B6366D2-3611-44D7-A870-AD30D885F6B2Q36479160-C9CB18AE-917D-4807-85EE-F489ECD99B3FQ36481620-7DEF9A84-C8E7-403A-AFDC-D71E6087C2F0Q36812111-3E359042-C6D9-4A7C-91E5-D41D35AAEF07Q36894451-525B7E23-49CB-4E08-9703-FA956DC09498Q38210526-D505C09E-8B05-4F38-A5A9-BA6200DDA99AQ39517876-2E317DE3-EF4F-4E34-9422-83DACDD6E9A5Q39671187-52F48E96-4B42-4AE6-AC9E-563FF39BBFC5Q39676787-C45EE823-193A-4AE9-A432-4D61039380FFQ39742025-7C295BFC-F1F6-4313-9384-8CC496A00348Q40520328-89DA62D8-A270-4481-8EC5-03285739DF68Q41961796-1BB3DB6E-AD09-4977-9C8A-554EA5F5A4DEQ55646843-A1922612-781D-43D2-BFEE-702BD06BCAB0
P2860
Administration of human fibroblast interferon in chronic hepatitis-B infection.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@en
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@nl
type
label
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@en
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@nl
prefLabel
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@en
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@nl
P2093
P1433
P1476
Administration of human fibroblast interferon in chronic hepatitis-B infection.
@en
P2093
A F Bradburne
J De Groote
J Desmyter
P De Somer
V J Desmet
P304
P356
10.1016/S0140-6736(76)92460-0
P407
P577
1976-09-01T00:00:00Z